| 000 | 01406naa a2200181uu 4500 | ||
|---|---|---|---|
| 001 | 6083011192621 | ||
| 003 | OSt | ||
| 005 | 20190211161202.0 | ||
| 008 | 060830s2006 xx ||||gr |0|| 0 eng d | ||
| 100 | 1 |
_aSHEINGATE, Adam D. _927592 |
|
| 245 | 1 | 0 |
_aPromotion Versus Precaution : _bThe Evolution of Biotechnology Policy in the United States |
| 260 |
_aNew York, NY : _bCambridge University Press, _cApril 2006 |
||
| 520 | 3 | _aBiotechnology policy in the United States promotes the commercial development of genetically modified crops, yet adopts a precautionary approach when it comes to stem cells and cloning. In this article, the evolution of this bifurcated policy domain is traced. A detailed analysis of congressional hearings shows how distinctions between the products of biotechnology came to be reflected in the character of committees holding hearings, the attention to risks and benefits, and the pattern of interest-group activity in different biotechnology applications. It is argued that many of the differences that separate the United States and Europe in biotechnology reflect the way institutions reinforce past policy choices. | |
| 773 | 0 | 8 |
_tBritish Journal of Political Science _g36, 2, p. 243-268 _dNew York, NY : Cambridge University Press, April 2006 _xISSN 0007-1234 _w |
| 942 | _cS | ||
| 998 |
_a20060830 _b1119^b _cNatália |
||
| 998 |
_a20081031 _b1055^b _cZailton |
||
| 999 |
_aConvertido do Formato PHL _bPHL2MARC21 1.1 _c19239 _d19239 |
||
| 041 | _aeng | ||